SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
LVRNA012-IIT-04
Unknown mab active
Quick answer
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine for SARS-CoV-2 is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- SARS-CoV-2
- Phase
- Unknown
- Modality
- mab
- Status
- active